MIP-1α is produced by macrophages and has the ability to induce the migration of monocytes, which then differentiate into dendritic cells (DCs) to recognize an antigen and activate tumor-specific T-cell responses via their potent antigen-presenting capacity to efficiently recognize and kill stem-like cancer cells [21–26]. The gene discussed is CCL3; the disease is cancer.